I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and Tolerability of ALK/MET Combinations in Patien..:
Ibiayi Dagogo-Jack, MD
;
Lesli A. Kiedrowski, MS, MPH
;
Rebecca S. Heist, MD, MPH
...
http://www.sciencedirect.com/science/article/pii/S2666364323000735. , 2023
Link:
https://doi.org/10.1016/j.jtocrr.2023.100534
RT Journal T1
Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:48f3d6a56b8d4f66bc9f438add97a0a8&Exemplar=1&LAN=DE A1 Ibiayi Dagogo-Jack, MD A1 Lesli A. Kiedrowski, MS, MPH A1 Rebecca S. Heist, MD, MPH A1 Jessica J. Lin, MD A1 Catherine B. Meador, MD, PhD A1 Elizabeth A. Krueger, NP A1 Andrew Do, BS A1 Jennifer Peterson, BS A1 Lecia V. Sequist, MD, MPH A1 Justin F. Gainor, MD A1 Jochen K. Lennerz, MD, PhD A1 Subba R. Digumarthy, MD PB Elsevier YR 2023 K1 ALK K1 MET amplification K1 Capmatinib K1 Crizotinib K1 Alectinib K1 Lorlatinib K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S2666364323000735 LK http://dx.doi.org/https://doi.org/10.1016/j.jtocrr.2023.100534 DO https://doi.org/10.1016/j.jtocrr.2023.100534 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)